What an incredible honour to be acknowledged as one of the most innovative companies in the East of England this year at #21toWatch campaign ✨
Supported by the cofinitive team including Faye Holland, Gemma Dorling, and Carole Aye Maung, and meticulously judged by Christine Martin, Chris Ellis, Thomas Hughes, and Jo Słota-Newson, the event on the 6th of March celebrated 7 people, 7 companies, and 7 things. Read more about that day in Cambridge Independent: https://www.cambridgeindependent.co.uk/business/21towatch-2025-winners-revealed-showcasing-emerging-innova-9407352/
Let us not overlook the shortlist and longlist of excellent candidates as well: https://www.cofinitive.com/21toWatch/
It was apparent that tackling brain diseases including Parkinson’s was a prominent theme, reflecting the growing challenge.
We appreciate everyone who is following us on this journey. In particular, the entrepreneurial Cambridge ecosystem provided us with the mentorship and network: Cambridge Judge Business School, impulse, Maxwell Centre, CONEXEN.
However, we also know that securing the award is only the beginning. Our goal is to advance our drug development with patient benefit in sight.
If you would like to explore partnerships and support of our mission – we would love to hear from you. Get in touch via LinkedIn or our webpage.
Special thanks to the sponsors of the event: Alan Boswell Group, Appleyard Lees IP LLP, Ashtons Legal LLP, Bailey Fisher Executive Search, BDO, Birketts LLP, Cambridge Management Consulting , CPCA Growth Hub, Foresight Group, HSBC Innovation Banking, Keltie, Marks & Clerk, Mishcon de Reya LLP, PEM, Penningtons Manches Cooper LLP, St John’s Innovation Centre Ltd
